Breast Cancer
Conference Coverage
Antibody drug conjugate induces responses in heavily pretreated TNBC
Key clinical point: Conjugating a metabolite of irinotecan to an antibody allows targeted delivery of the otherwise highly toxic drug. Major...
Article
Balancing clinical and supportive care at every step of the disease continuum
News
Pan-AKT inhibitor shrinks tumors in patients with AKT1 mutation
A novel pan-AKT inhibitor shrinks tumors in patients harboring a mutation in AKT1.
Conference Coverage
AHA: Candesartan protects against cardiotoxicity in breast cancer patients in PRADA
Candesartan prevents early decrease in LVEF during breast cancer adjuvant therapy.
Conference Coverage
Decision model shows prophylactic double mastectomy more costly to patients
Key clinical point: Unilateral mastectomy costs less and provides better quality of life than contralateral prophylactic mastectomy in younger...
Article
ACOG plans consensus conference on uniform guidelines for breast cancer screening
Confused about which guidelines for breast cancer screening to follow in average-risk women? ACOG takes action with an upcoming consensus...
Article
Adjuvant Systemic Therapy for Early-Stage Breast Cancer
News
How to individualize cancer risk reduction after a diagnosis of DCIS
With proper patient counseling and careful decision making, you can reduce the risk of recurrence and invasive disease without overtreating the...
News
Partial breast irradiation valid option to prevent local recurrence
Key clinical point:Accelerated partial breast irradiation (APBI) was as effective as whole breast irradiation (WBI) plus a boost in preventing...
News
Gene mutations had little impact on everolimus benefit in advanced breast cancer
Key clinical point: Mutations in genes involved in the PI3K/mTOR pathway, FGFR signaling, and cell cycle regulation had little impact on...